Microglia mediate neuroinflammation and regulate brain development and homeostasis. Microglial abnormalities are implicated in a range of neuropsychiatric pathology, including Tourette syndrome (TS) and autism. Histamine (HA) is both a neurotransmitter and an immune modulator. HA deficiency has been implicated as a rare cause of TS and may contribute to other neuropsychiatric conditions. In vitro studies suggest that HA can regulate microglia, but this has never been explored in vivo. We used immunohistochemistry to examine the effects of HA deficiency in histidine decarboxylase (Hdc) knockout mice and of HA receptor stimulation in wild-type animals. We find HA to regulate microglia in vivo, via the H4 receptor. Chronic HA deficiency in Hdc knockout mice reduces ramifications of microglia in the striatum and (at trend level) in the hypothalamus, but not elsewhere in the brain. Depletion of histaminergic neurons in the hypothalamus has a similar effect. Microglia expressing IGF-1 are particularly reduced, However, the microglial response to challenge with lipopolysacchariade (LPS) is potentiated in Hdc knockout mice. Genetic abnormalities in histaminergic signaling may produce a vulnerability to inflammatory challenge, setting the state for pathogenically dysregulated neuroimmune responses.
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Introduction
Histamine (HA) is produced both by immune cells and by a group of neurons in the posterior tuberomamillary nucleus of the hypothalamus; in the central nervous system it functions as a neurotransmitter, with diverse functions in different circuitries (Haas et al., 2008) . Histamine receptors are prominent in many brain regions, especially in the cortico-basal ganglia circuitry (Haas et al., 2008) . Dysregulation of brain histamine is increasingly appreciated as a potential contributor to neuropsychiatric disease (Panula and Nuutinen, 2013) . For example, disruption of histamine biosynthesis has been implicated as a rare genetic cause of Tourette syndrome (TS; Castellan Baldan et al., 2014; Ercan-Sencicek et al., 2010; Fernandez et al., 2012; Karagiannidis et al., 2013) . Abnormalities in histaminergic signaling have also been hypothesized to contribute to Parkinson's disease (Shan et al., 2012 ), Huntington's disease (van Wamelen et al., 2011; Goodchild et al., 1999) , Alzheimer disease's (Shan et al., 2012; Naddafi and Mirshafiey, 2013) , narcolepsy (John et al., 2013; Valko et al., 2013) , and drug addiction (Haas et al., 2008; Panula and Nuutinen, 2013) .
Peripheral HA is an important modulator of immune, inflammatory, and allergic responses (e.g. Passani and Ballerini, 2012; Wernersson and Pejler, 2014) . Dysregulated neuroinflammation has been proposed to contribute to TS and a variety of other neuropsychiatric conditions (Hornig and Lipkin, 2013; Mitchell and Goldstein, 2014; Frick et al., 2013) , although these connections remain unproven in most cases. The possible role of HA as a regulator of neuroinflammatory processes in the brain has received scant attention.
Microglia are the primary inflammatory cells in the brain; inflammatory challenge, such as administration of lipopolysaccharide (LPS), induces them to produce inflammatory cytokines such as interleukin-1b (IL-1b) and tumor necrosis factor-a (TNF-a). More recently it has been appreciated that microglia are required for normal brain development, homeostasis, synaptic function, and adult neurogenesis, even in the absence of inflammation (Ji et al., 2013; Schafer et al., 2013; Zhan et al., 2014 
